Skip to main content
Clinical Trials/IRCT20181231042183N1
IRCT20181231042183N1
Recruiting
Phase 3

Comparison Bopronorphin and Morphin Among NeonatesWith Obstinence Syndrom Admitted In Birjand Vali-asr Hospital

Birjand University of Medical Sciences0 sites60 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Birjand University of Medical Sciences
Enrollment
60
Status
Recruiting
Last Updated
7 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
7 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Postnatal Age\<7 Days
  • Gestational Age\= 35 Weeks
  • Prenatal Opium Exposure
  • Symptomatic Patient And 3 Fingan Score \=8 In 3 Hours Or 2 Fingan Score\=12
  • No Siezure History
  • No Major Congenital Anomaly
  • No Unstablity In Blood Pressure And Hemodynamic
  • No Major Medical Unstability In Association Of Withdrawal Syndrome

Exclusion Criteria

  • Analgesic Consumption and withdrawal syndrome

Outcomes

Primary Outcomes

Not specified

Similar Trials